| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-25-100456 |
2025-04-28 16:05:39 |
DEF 14A
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001172661-24-004705 |
2024-11-13 17:55:04 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000315066-23-002263 |
2023-05-10 09:45:10 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-126925 |
2023-04-28 16:08:58 |
DEF 14A
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001104659-23-050861 |
2023-04-27 10:00:34 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001493152-23-013356 |
2023-04-24 16:05:26 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001104659-23-031755 |
2023-03-13 16:01:41 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001104659-23-029008 |
2023-03-06 16:11:23 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001104659-23-028984 |
2023-03-06 16:00:26 |
SC 13D
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000947871-23-000250 |
2023-02-28 16:00:03 |
SC 13D
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001104659-22-110941 |
2022-10-24 16:43:00 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001493152-22-029422 |
2022-10-24 16:31:23 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-114052 |
2022-04-22 06:19:03 |
DEF 14A
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001567619-22-008510 |
2022-04-14 10:13:51 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-21-165316 |
2021-05-18 16:06:03 |
DEF 14A
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-21-027355 |
2021-02-03 16:31:51 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000315066-20-001598 |
2020-06-10 10:13:20 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000078003-20-000027 |
2020-03-26 16:21:03 |
SC 13G
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-20-083815 |
2020-03-24 16:15:35 |
SC 13D
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000947871-20-000244 |
2020-03-20 17:08:35 |
SC 13D
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001072613-20-000132 |
2020-03-20 12:28:35 |
SC 13D
|
